HedgeMountain

Verdad Biotech Fund, L.P.

Boston, MA · CIK 2139106
Emerging

Verdad Biotech Fund, L.P. is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jun 9, 2026, the fund has sold $8,099,001 of interests to 9 investors since its first sale in Apr 2026. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, HedgeMountain classifies it as an emerging manager. Related persons named in the filing include Verdad Asset Management; Dan Rasmussen; VCLF GP, L.p.

Performance

No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$8,099,001Cumulative sales reported on Form D
Investors
9
First sale
Apr 1, 2026
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Verdad Asset Management; Dan Rasmussen; VCLF GP, L.p
Latest Form D
Jun 9, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures

Size compared with every hedge fund

Raised more than 14% of the 472 hedge funds based in Massachusetts, and more than 19% of all 10,157 that report sales.

Other funds with the same team

More hedge funds in Boston